Category: Mergers and Acquisitions

Mergers and Acquisitions, News

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

March 23, 2021

Via: BioSpace

Anixa Biosciences, Inc. (NASDAQ: ANIX) (“Anixa” or the “Company”), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that, due to demand, the underwriter has agreed to increase the size of the previously […]

Cell and Gene Therapy, Industry, Mergers and Acquisitions

Tmunity Therapeutics Announces Expansion of T Cell Engineered Therapy Collaboration

February 9, 2021

Via: BioSpace

Tmunity Therapeutics, Inc., a clinical-stage biotherapeutics company specifically designed to deliver on the bold promise to ‘uncancer the world’ by creating the best T cell medicines for solid tumor patients, today announced the expansion of its T cell engineered therapy […]

Mergers and Acquisitions

Jazz Pharmaceuticals to acquire GW Pharma for $7.2bn

February 8, 2021

Via: Pharma Times

Jazz Pharmaceuticals has announced that it will acquire London-headquartered biopharma company GW Pharma for a total consideration of $7.2bn. GW is focused on the discovery and development of therapeutics from its proprietary cannabinoid product platform. The company’s lead product is […]

Mergers and Acquisitions

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering – Feb 05, 2021

February 5, 2021

Via: BioSpace

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced the pricing of its public offering of 5,000,000 shares of its common stock at a […]

Mergers and Acquisitions, News

Stella Diagnostics Announces Partnership with mProbe Laboratories

February 4, 2021

Via: BioSpace

Stella Diagnostics, Inc. (OTC PINK:JMDP) (“Stella” or “The Company”) announced today that they have entered into a partnership with mProbe, Inc., a leading biotechnology company based in California. The aims of the partnership were to build, optimize and further validate […]

Mergers and Acquisitions

Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex

December 31, 2020

Via: BioSpace

Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and […]

FDA, Mergers and Acquisitions, Regulations

As Urovant gears up for vibegron FDA decision, the biotech gets snapped up by Sumitovant Biopharma

November 13, 2020

Via: FierceBiotech

Urovant began life as an offshoot of Vivek Ramaswamy’s Roivant goliath, but is now firmly a part of the Sumitovant Biopharma family after the life science company bought up the rest of its shares in the biotech. This comes around […]

Cell and Gene Therapy, Industry, Mergers and Acquisitions

Bayer to Pay up to $4B for Gene Therapy Firm AskBio

October 28, 2020

Via: Contract Pharma

Bayer AG has acquired Asklepios BioPharmaceutical, Inc. (AskBio) for $2 billion upfront and potential success-based milestone payments of up to $2 billion. The U.S.-headquartered biopharma specializes in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s […]

Mergers and Acquisitions

J&J to Acquire Momenta Pharmaceuticals for $6.5B

August 19, 2020

Via: Contract Pharma

Johnson & Johnson has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. for approximately $6.5 billion in cash. This acquisition expands Janssen Pharmaceutical’s portfolio in immune-mediated diseases into autoantibody-driven disease. J&J gains global rights to nipocalimab (M281), a […]

Mergers and Acquisitions

EU and US Discuss Regulatory Collaboration

June 23, 2020

Via: PharmTech

Members of the European Commission, the European Medicines Agency, and the US FDA held their 2020 bilateral regulatory meeting virtually from June 18–19, 2020. The agencies discussed ongoing joint initiatives and strategies for collaborating in the future. The agencies, which […]

Mergers and Acquisitions, News

PDS Biotechnology and Farmacore Biotechnology

June 19, 2020

Via: Genetic Engineering and Biotechnology News

PDS Biotechnology said June 17 that it signed an agreement with Farmacore Biotechnology to co-develop Versamune®-CoV-2FC. PDS and Farmacore agreed to accelerate development of the vaccine candidate into Phase 1 clinical testing in Brazil, with initial financial support to be […]

Mergers and Acquisitions, News

Novavax Contracts to Expand Adjuvant Production

June 4, 2020

Via: Biopharm International

Novavax, a late-stage biotechnology company developing the NVX-CoV2373 coronavirus vaccine candidate against SARS-CoV-2 has secured two manufacturing agreements for large-scale GMP (good manufacturing practice) manufacture of components of the vaccine candidate. NVX CoV2373 is engineered from the genetic sequence of […]